1. Vgontzas AN, Kales A. Sleep and its disorders. Annu Rev Med 1999;50:387-400
2. Borbely AA: A two process model of sleep regulation. Hum Neurobiol 1:195-204, 1982
3. Czeisler CA, Weitzman ED, Moore-Ede MC, Zimmerman JC, Knauer RS. Human sleep: its duration and organization depend on its circadian phase. Science 210:1264-1267, 1980
4. Rechtschaffen A, Kales A: A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages of Human Subjects, Bethesda: National Institutes of Health, NIH Rep No 204; 1968
5. Bixler EO, Kales A, Soldatos CR, Kales JD, Healey S: Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1136:1257-1262, 1979
6. Lugaresi E, Cirignotta F, Zucconi M, et al: Good and poor sleepers: An epidemiological survey of the San Marino population, In Guilleminault C, Lugaresi C (eds): Sleep/Wake Disorders: Natural History, Epidemiology and Long-Term Evoluation, New York: Plenum Press (pp. 1-12), 1983
7. Kales A, Kales J: Evaluation and Treatment of Insomnia, New York, Oxford University Press, 1984
8. Buysse DJ, Reynolds CF III, Hauri PJ, Roth T, Stepanski EJ, Thorpy MJ, et al: Diagnostic concordance for DSM-IV sleep disorders: A report from the APA/ NIMH DSM-IV field trial. Am J Psychiatry 151:1351-1360, 1994
9. Ford DE, Kamerow DB: Epidemiologic study of sleep disturbances and psychiatric disorders. JAMA 262:1479-1484, 1989
10. Vgontzas AN, Bixler EO, Tan TL, Kantner D, Martin LF, Kales A: Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med 158:1333-1337, 1998
11. Bixler EO , Vgontzas AN , Lin HM , Calhoun SL , Vela-Bueno A , Kales A . Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab. 2005 Aug;90(8):4510-5, 2005
12. Basta M , Lin HM , Pejovic S , Sarrigiannidis A , Bixler E , Vgontzas AN . Lack of regular exercise, depression, and degree of apnea are predictors of excessive daytime sleepiness in patients with sleep apnea: sex differences. J Clin Sleep Med. 2008 Feb 15;4(1):19-25, 2008
13. Bixler EO, Vgontzas AN, Lin H, Leiby B, Kales A: Excessive daytime sleepiness: association with diabetes. Endocrine Society's 83rd Annual Meeting, Denver, CO, June 20-23, 2001
14. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362, 1995
15. Chrousos GP, Gold PW: The concepts of stress and stress system disorders. JAMA 267:1244-1252, 1992
16. Chrousos GP, Loriaux DL, Gold PW (eds): Mechanisms of Physical and Emotional Stress. Advances in Experimental Medicine and Biology, New York: Plenum Press, Vol. 245, 1988
17. Weitzman ED, Zimmerman JC, Czeisler CA: Cortisol secretion is inhibited during sleep in normal man. J Clin Endocrinol Metab 56:352, 1983
18. Opp M: Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Adv Neuroimmunol 5:127-143, 1995
19. Opp M, Obál Jr F, Krueger JM: Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am J Physiol 257:R528-R535, 1989
20. Chrousos GA, Kattah JC, Beck RW, Cleary PA: Side effects of glucocorticoid treatment. JAMA 269:2110-2112, 1993
21. Born J, Kern W, Bieber K, Fehm-Wolfsdorf G, Schiebe M, Fehm HL: Night-time plasma cortisol secretion is associated with specific sleep stages. Biol Psychiatry 21:1415-1424, 1986
22. Follenius M, Brandenberger G, Bandesapt JJ, Libert JP, Ehrhart J: Nocturnal cortisol release in relation to sleep structure. Sleep 15:21-27, 1992
23. Späth-Schwalbe E, Gofferje M, Kern W, Born J, Fehm HL: Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 29:575-584, 1991
24. Steiger A, Holsboer F: Neuropeptides and human sleep. Sleep 20:1038-1052, 1997
25. Mandell MP, Mandell AJ, Rubtin RT, Brill P, Rodnick J, Sheff R, et al: Activation of the pituitary-adrenal axis during rapid eye movement sleep in man. Life Sci 5:583-587, 1966
26. Vgontzas AN, Bixler EO, Papanicolaou, Kales A, Stratakis CA, Vela-Bueno A, et al: Rapid eye movement sleep correlates with the overall activities of the hypothalamic-pituitary-adrenal axis and sympathetic system in healthy humans. J Clin Endocrinol Metab 82:3278-3280, 1997
27. Born J, Spath-Schwalbe E, Schwakenhofer H, Kem W, Fehm HL: Influences of corticotropin-releasing hormone, adreno-corticotropin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 68:904-911, 1989
28. Kellner M, Yassouridis A, Manz B, Steiger A, Holsboer F, Wiedemann K: Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers: A potential link to low-melatonin syndrome in depression? Neuroendocrinology 65:284-290, 1997
29. Mann K, Roschke J, Benkert O, Aldenhoff J, Nink M, Beyer J, et al: Effects of corticotropin-releasing hormone on respiratory parameters during sleep in normal men. Exp Clin Endocrinol Diabetes 103:233-240, 1995
30. Vgontzas AN, Bixler EO, Wittman AM, Zachman K, Lin H, Vela-Bueno A, et al: Middle-aged men show higher sensitivity of sleep to the arousing effects of corticotropin-releasing hormone than young men: Clinical implications. J Clin Endocrinol Metab 86:1489-1495, 2001
31. Gillin JC, Jacobs LS, Fram DH, Snyder F: Acute effect of a glucocorticoid on normal human sleep. Nature 237:398-399, 1972
32. Steiger A, Antonijevic A, Bohlhalter S, Frieboes RM, Friess E, Murck H: Effects of hormones on sleep. Horm Res 49:125-130, 1998
33. García-Borreguero D, Wehr TA, Larrosa O, Granizo JJ, Hardwick D, Chrousos GP, et al: Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency. J Clin Endocrinol Metab 85:4201-4206, 2000
34. Van Cauter E, Leproult R, Plat L: Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 284(7):861-868, 2000
35. Van Cauter E, Leproult R, Kupfer DJ: Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81:2468-2473, 1996
36. Vgontzas AN, Zoumakis M, Bixler EO, Lin H, Prolo P, Vela-Bueno A, Kales A, Chrousos GP: Impaired nighttime sleep in healthy old vs. young adults is associated with elevated plasma IL-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab 2003 May;88(5):2087-95, 2003.
37. Prinz P, Bailey S, Moe, K: Urinary free cortisol and sleep under baseline and stressed conditions in healthy senior women: Effects of estrogen replacement therapy. J Sleep Res 10:19-26, 2001
38. Brun J, Chamba G, Kihalfallah Y, Girard P, Boissy I, Bastuji H, et al: Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation. J Sleep Res 7:105-114, 1998
39. Moldofsky H, Lue FA, Davidson JR, Gorczynski R: Effects of sleep deprivation on human immune functions. FASEB J 3:1927-1977, 1989
40. Scheen AJ, Byrne MM, Plat L, Leproult R, Van Cauter E: Relationships between sleep quality and glucose regulation in normal humans. Am J Physiol 271 (Endocrinology Metabolism 34) E261-E270, 1996
41. Leproult R, Copinschi G, Buxton O, Van Cauter E: Sleep loss result in an elevation of cortisol levels the next evening. Sleep 20:865-870, 1997
42. Vgontzas AN, Mastorakos G, Bixler EO, Kales A, Gold PW, Chrousos GP: Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: Potential clinical implications. Endocrinol 51:205-215, 1999
43. Spiegel K, Leproult R, Van Cauter E: Impact of sleep debt on metabolic and endocrine function. Lancet 354(9188):1435-1439, 1999
44. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, Chrousos GP. Adverse effects of modest sleep restriction on Sleepiness, Performance and inflammatory cytokines. J Clin Endocrinol Metab 89:2119-2126, 2004
45. Vgontzas AN, Pejovic S, Zounakis E, Lin HM, Bixler EO, Basta M, Fang J, Sarrigiannidis A, Chrousos GP. Daytime napping after a night of sleep loss decreases sleepiness, improves performance and causes beneficial changes in cortisol and IL-6 secretion. Am. J.Physiol. Endocrinol Metab 292:E253-261, 2006
46. Rechtschaffen A, Bergmann BM, Everson CA, Kushida CA, Gilliland MA: Sleep deprivation in the rat. X. Integration and discussion of the findings. Sleep 12:68-87, 1989
47. Adams K, Tomeny M, Oswald I: Physiological and psychological differences between good and poor sleepers. J Psychiatric Res 20:301-316, 1986
48. Vgontzas AN, Tsigos C, Bixler EO, Stratakis CA, Zachman K, Kales A, et al: Chronic insomnia and activity of the stress system: A preliminary study. J Psychosom Res 45(1):21-31, 1998
49. Vgontzas AN, Bixler EO, Lin H-M, Prolo P, Mastorakos G, Vela-Bueno A, et al: Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 86:3787-3794, 2001
50. Rodenbeck A, Heuther G, Ruther E, Hajak G: Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia: Neurosci Lett 324(2):154-163, 2002
51. Riemann D, Klein T, Rodenbeck A, Feige B, Horny A, Hummel R, Weske G, Al-Shajlawi A, Voderholzer U: Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Research 113:17-27, 2002
52. Varkevisser M, Van Dongen HPA, Kerkhof GA. Physiologic Indexes in chronic insomnia during constant routine: Evidence for general hyperarousal? Sleep 2005;28(12): 1588-1596, 2005
53. Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertention . Sleep. 2009 Apr 1;32(4):491-7, 2009
54. Vgontzas AN , Liao D , Pejovic S , Calhoun S , Karataraki M , Bixler EO . Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care 2009 Nov;32(11):1980-5, 2009
55. Fernandez-Mendoza J, Calhoun S, Bixler EO, Pejovic S, Karataraki M, Liao D, Vela-Bueno A, Ramos-Platon MJ, Sauder KA, Vgontzas AN. Insomnia with objective short sleep duration is associated with deficits in neuropsychological performance: a general population study. Psychosom Med 2010 may;72(4)397-403, 2010.
56. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Basta M, Fernandez-Mendoza J, Bixler EO. Insomnia with short sleep duration and Mortality: The Penn State Cohort. Sleep 2010;33(9):1159-1164, 2010
57. Michelson D, Galliven E, Hill L, Demitrack M, Chrousos G, Gold P: Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans. J Clin Endocrinol Metab 82:2610-2606, 1997
58. Hajak G, Rodenbeck A, Adler L, Huether G, Bandelow B, Herrendorf G: Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia. Pharmacopsychiatry 29:187-192, 1996
59. Hohagen F, Montero RF, Weiss E, Lis S, Schonbrunn E, Dressing H, et al: Treatment of primary insomnia with trimipramine: An alternative to benzodiazepine hypnotics? Eur Arch Psychiatry Clin Neurosci 224:65-72, 1994
60. Rodenbeck A, Cohrs S, Jordan W, Huether G, Ruther E, Hajak G. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology 170:423-428, 2003
61. Roth T, Rogowski R, Hull S, Schwartz H, Koshorek G, Corser B, Seiden D, Lankford A. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. Sleep. 2007 Nov 1;30(11):1555-61, 2007
62. Roth T, Heith Durrence H, Jochelson P, Peterson G, Ludington E, Rogowski R, Scharf M, Lankford A. Efficacy and safety of doxepin 6 mg in a model of transient insomnia. Sleep Med. 2010 Oct;11(9):843-7, 2010
63. Fletcher EC, Miller J, Schaaf JW, Fletcher JG: Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10:35-44, 1987
64. Waradekar NV, Sinoway LI, Zwillich CW, Leuenberger UA: Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153:1333-1338, 1996
65. Mills PJ, Kennedy BP, Loredo JS, Dimsdale JE, Ziegler MG. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 2006; 100 :343–8.
66. Vgontzas AN , Zoumakis E , Bixler EO , Lin HM , Collins B , Basta M , Pejovic S , Chrousos GP . Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest. 2008 Aug;38(8):585-95.
67. Entzian P, Linnemann K, Schlaak M, Zabel P: Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 153:1080-1086, 1996
68. Guilleminault C, Dement WC: Sleep Apnea Syndromes, New York: Alan R Liss, 1978
69. Grunstein RR, Stewart DA, Lloyd H, Akinci M, Cheng N, Sullivan CE: Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones. Sleep 19(10):774-782, 1996
70. Bratel T, Wennlund A, Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnea. Effects of continuous positive airway pressure treatment (CPAP) Respir Med 93:1-7, 1999.
71. Vgontzas AN, Pejovic S, Zoumakis E, Lin HM, Bentley CM, Bixler EO, Sarrigianidis A, Basta M, Chrousos GP. Hypothalamic-Pituitary-Adrenal Axis activity in obese men with and without Sleep Apnea: Effects of Continuous Positive Airway Pressure therapy. J Clin Endocrinol Metab 92:4199-4207, 2007
72. Henley DE, Russell GM, Douthwaite JA, Wood SA, Buchanan F, Gibson R, Woltersdorf WW, Catterall JR, Lightman SL. Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab . 2009 Nov;94(11):4234-42
73. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Vela-Bueno A, Myers D, et al: Evidence of corticotropin-releasing hormone (CRH) deficiency in patients with idiopathic hypersomnia: Clinical and pathophysiological implications. Endocrine Society's 79th Annual Meeting, Minneapolis, MN, June 11-14, 1997
74. Kok SW, Roelfsema F, Overeem S, Lammers GJ, Strijers RL, Frölich M, Meinders AE, Pijl H: Dynamics of the pituitary-adrenal ensemble in hypocretin-deficient narcoleptic humans: blunted basal adrenocorticotropin release and evidence for normal time-keeping by the master pacemaker. J Clin Endocrinol Metab 87(11):5085-91, 2002
75. Shipley JE, Schteingart DE, Tandon R, Starkman MN. Sleep architecture and sleep apnea in patients with Cushing's disease. Sleep 15:514-518, 1992
76. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin H, et al: Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85:1151-1158, 2000
77. Friedman TC, García-Borreguero D, Hardwick D, Akuete CN, Doppman JL, Dorn LD, et al: Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome. Neuroendocrinology 60:626-634, 1994
78. Papanicolaou DA, Tsigos C, Oldfield EH, Chrousos GP: Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: Does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J Clin Endocrinol Metab 81:2303-2306, 1996
79. Reincke M, Heppner C, Petzke F, Allolio B, Arlt W, Mbulamberi D, et al: Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in African trypanosomiasis. Neuroimmunomodulation 1:14-22, 1994
80. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332(20):1351-1362, 1995
81. Krueger JM, Walter J, Dinarello CA, Wolff SM, Chedid L: Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol 246:R994-R999, 1984
82. Tobler I, Borbély AA, Schwyzer M, Fontana A: Interleukin-1 derived from astrocytes enhances slow wave activity in sleep EEG of the rat. Eur J Pharmacol 104:191-192, 1984
83. Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E: Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol 129:2413-2419, 1982
84. Shoham S, Davenne D, Cady AB, Dinarello CA, Krueger JM: Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 253:R142-R149, 1987
85. Walter JS, Meyers P, Krueger JM: Microinjection of interleukin-1 into brain: Separation of sleep and fever responses. Physiol Behav 45:169-176, 1989
86. Kapás L, Krueger JM: Tumor necrosis factor-beta induces sleep, fever, and anorexia. Am J Physiol 263:R703-R707, 1992
87. Bredow S, Taishi P, Guha-Thakurta N, Obal F Jr, Krueger JM: Diurnal variations of tumor necrosis facor-a mRNA anda-tubulin mRNA in rat brain. Neuroimmunomodulation 4:84-90, 1997
88. Floyd RA, Krueger JM: Diurnal variation of TNFa in the rat brain. NeuroReport 8:915-918, 1997
89. Takahashi S, Kapás L, Fang L, Krueger JM: An anti-tumor necrosis factor antibody suppresses sleep in rats and rabbits. Brain Res 690:241-244, 1995
90. Fang J, Wang Y, Krueger JM: Mice lacking the TNF 55 kDa receptor fail to sleep more after TNFa treatment. J Neurosci 17:5949-5955, 1997
91. Moldofsky H, Lue FA, Eisen J, Keystone E, Gorczynski RM: The relationship of interleukin-1 and immune functions to sleep in humans. Psychosom Med 48:309-318, 1986
92. Darko DF, Miller JC, Gallen C, White J, Koziol J, Brown SJ, et al: Sleep electroencephalogram delta frequency amplitude, night plasma levels of tumor necrosis factor a and human immunodeficiency virus infection. Proc Natl Acad Sci U S A 92:12080-12086, 1995
93. Covelli V, D'Andrea L, Savastano S, Valentino R, Tommaselli AP, Selleri A, et al: Interleukin-1 beta plasma secretion during diurnal spontaneous and induces sleeping in healthy volunteers. Acta Neurol (Napoli) 16:79-86, 1994
94. Gudewill S, Pollmacher T, Vedder H, Schreiber W, Fassbender K, Holsboer F: Nocturnal plasma levels of cytokines in healthy men. Eur Arch Psychiatry Clin Neurosci 242:53-56, 1992
95. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, et al: Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84:2603-2607, 1999
96. Bauer J, Hohagen T, Ebert J, Timmer J, Ganter U, Krieger S, et al: Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. Clin Invest 72:315, 1994
97. Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, et al: Circadian relationships between interleukin (IL-6) and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 82:1279-1283, 1997
98. Sothern RB, Roitman-Johnson B, Kanabrock EL, Yager JG, Fuerstenberg RR, Weatherbee JA, et al: Circadian characteristics of interleukin-6 in blood and urine of clinically healthy men. In Vivo 9:331-340, 1995
99. Fernandez-Real, J-M, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, et al: Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86:1154-1159, 2001
100. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128:127-137, 1998
101. Mastorakos G, Chrousos GP, Weber JS: Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77:1690-1694, 1993
102. Späth-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, et al: Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 83:1578-1579, 1998
103. Vgontzas AN, Zoumakis M, Bixler EO, Lin H, Prolo P, Vela-Bueno A, Kales A, Chrousos GP: Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab. 2003 May;88(5):2087-95 , 2003
104. Ershler WB, Keller ET (Review): Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245-70, 2000
105. Vgontzas AN, Zoumakis M, Papanicolaou DA, Bixler EO, Prolo P, Lin HM, et al: Chronic insomnia is associated with a shift of IL-6 and TNFa secretion from nighttime to daytime. Metabolism 51(7):887-92, 2002
106. Vgontzas AN, Chrousos GP: Sleep, the hypothalamic-pituitary-adrenal axis and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol Metab Clin N Am 31:15-36, 2002
107. Gold PW, Chrousos GP: Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Molecular Psychiatry 7:254-275, 2002
108. Chrousos GP, Gold PW: A healthy body in a healthy mind - vice versa -: the damaging power of "uncontrollable" stress (Editorial). J Clin Endocrinol Metab 83:1842-1845, 1998
109. Clauw DJ, Chrousos GP: Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4:134-153, 1997
110. Partinen M: Sleeping habits and sleep disorders of Finnish men before, during, and after military service. Ann Med Milit Fenn 57(suppl):96, 1982
111. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313-1316, 1997
112. Hinze-Selch D, Wetter TC, Zhang Y, Lu HC, Albert ED, Mullington J: In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology 50(4):1149-1152, 1998
113. Shearer WT, Reuben JM, Mullington JM, et al.: Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 107(1):19-20, 2001
114. Redwine L, Hauger RL, Gillin JC, Irwin M: Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab 85:3597-3603, 2000
115. Obal FJ, Krueger JM. Biochemical regulation of non-rapid-eye movement sleep. Front Biosci 2003;8:520-50, 2003
116. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP (2004). Marked decrease in sleepiness in patients with sleep apnea by Etanercept, a Tumor Necrosis Factor-a antagonist. J Clin Endocrinol Metab 89:4409-4413, 2004
117. Bonnett MH, Arand DL: The consequences of a week of insomnia. Sleep 19:453-461, 1996
118. Stepanski E, Zorick F, Roehrs T, Young D, Roth T: Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep 11:54-60, 1988
119. Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a Standard Research Assessment of Insomnia. Sleep ;29(9):1155-1173, 2006
120. Mullington JC, Korth D, Hermann A, et al.: Dose-dependent effects of endotoxin on human sleep. Am J Physiol 278:R947-955, 2000